BSE Live
Oct 10, 16:01Prev. Close
437.60
Open Price
433.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 10, 15:55Prev. Close
438.10
Open Price
438.10
Bid Price (Qty.)
435.45 (17)
Offer Price (Qty.)
0.00 (0)
Cash Flow of Panacea Biotec (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | -7.95 | 1.48 | 12.81 | 1,448.81 | -145.03 | |
Net CashFlow From Operating Activities | -27.37 | -0.10 | -422.45 | -108.44 | 106.76 | |
Net Cash Used In Investing Activities | 64.98 | 10.23 | 430.33 | 1,282.57 | -47.68 | |
Net Cash Used From Financing Activities | -2.66 | -2.81 | -18.37 | -1,175.85 | -47.11 | |
Foreign Exchange Gains / Losses | 0.01 | 0.00 | 0.00 | -0.01 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 34.96 | 7.32 | -10.50 | -1.73 | 11.98 | |
Cash And Cash Equivalents Begin of Year | 47.17 | 39.85 | 50.35 | 52.08 | 40.22 | |
Cash And Cash Equivalents End Of Year | 82.13 | 47.17 | 39.85 | 50.35 | 52.19 |
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
24.04.2025
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
28.11.2024
Panacea Biotec Consolidated September 2024 Net Sales at Rs 147.35 crore, up 3.03% Y-o-Y